Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001558370-20-001395
Filing Date
2020-02-26
Accepted
2020-02-26 07:52:57
Documents
3
Period of Report
2019-08-31

Document Format Files

Seq Description Document Type Size
1 6-K f6-k.htm 6-K 26182
2 EX-99.1 ex-99d1.htm EX-99.1 823052
3 EX-99.2 ex-99d2.htm EX-99.2 667017
  Complete submission text file 0001558370-20-001395.txt   1517278
Mailing Address DARWINWEG 24 LEIDEN P7 2333CR
Business Address DARWINWEG 24 LEIDEN P7 2333CR 31(0)88 166 7000
ProQR Therapeutics N.V. (Filer) CIK: 0001612940 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36622 | Film No.: 20653333
SIC: 2834 Pharmaceutical Preparations